
07/24/2025
A new study suggests industry ties may influence GLP‑1 prescribing guidelines for teens, raising concerns about conflicts of interest and the balance between medical innovation and unbiased care. Read more.
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed financial ties to obesity drugmakers, a paper finds.